Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Yi-Bin A. Chen, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01643668
First received: June 12, 2012
Last updated: October 3, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)